Cost-effectiveness of psychotherapy for cluster C personality disorders: A decision-analytic model in The Netherlands

Journal of Clinical Psychiatry

Volumn 72, Issue 1, 2011, Pages 51-59

  Soeteman, Djøra I ^a,c   Verheul, Roel ^b,c   Meerman, Anke M M A ^d   Ziegler, Uli ^e   Rossum, Bert V ^f   Delimon, Jos ^c   Rijnierse, Piet ^g   Thunnissen, Moniek ^h   Busschbach, Jan J V ^a,c   Kim, Jane J ⁱ  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Viersprong Institute for Studies on Personality Disorders VISPD   (Netherlands)

^d Center of Psychotherapy de Gelderse Roos   (Netherlands)

^e Medical Center Zaandam   (Netherlands)

^f Altrecht   (Netherlands)

^g Center of Psychotherapy Arkin   (Netherlands)

^h GGZ Westelijk Noord Brabant   (Netherlands)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AVOIDANT PERSONALITY DISORDER; CONVALESCENCE; COST EFFECTIVENESS ANALYSIS; DAY HOSPITAL; DEPENDENT PERSONALITY DISORDER; ECONOMIC EVALUATION; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; MONEY; NETHERLANDS; OBSESSIVE COMPULSIVE DISORDER; OUTPATIENT CARE; PARAMETER; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY ADJUSTED LIFE YEAR;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; CLUSTER ANALYSIS; COST-BENEFIT ANALYSIS; DAY CARE; DECISION SUPPORT TECHNIQUES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INTENTION TO TREAT ANALYSIS; LENGTH OF STAY; MALE; MIDDLE AGED; MODELS, STATISTICAL; NETHERLANDS; PERSONALITY DISORDERS; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; QUALITY-ADJUSTED LIFE YEARS;

EID: 79551515163     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05228blu     Document Type: Article

References (35)

1. Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 2001;58(6):590-596. doi:10.101/archpsyc.58.6.590 (Pubitemid 32523740)
2. Lenzenweger MF, Lane MC, Loranger AW, et al. DSM-IV personality disorders in the national comorbidity survey replication. Biol Psychiatry. 2007;62(6):553-564. doi:10.1016/j.biopsych.206.09.019 (Pubitemid 47314365)
3. Soeteman DI, Hakkaart-van Roijen L, Verheul R, et al. The economic burden of personality disorders in mental health care. J Clin Psychiatry. 2008;69(2):259-265. doi:10.408/JCP.v69n0212 (Pubitemid 351469269)
4. Soeteman DI, Verheul R, Busschbach JJV. The burden of disease in personality disorders: diagnosis-specific quality of life. J Pers Disord. 2008;22(3):259-268. doi:10.1521/pedi.208.2.3.259
5. Bender DS, Dolan RT, Skodol AE, et al. Treatment utilization by patients with personality disorders. Am J Psychiatry. 2001;158(2):295-302. doi:10.176/api.ajp.158.2.295 (Pubitemid 32116528)
6. Landelijke Stuurgroep Richtlijnontwikkeling in de GGZ. Multidisciplinaire Richtlijn Persoonlijkheidsstoornissen [Multidisciplinary Clinical Guideline of Personality Disorders]. Utrecht, The Netherlands: Trimbos-instituut; 2008.
7. Verheul R, Herbrink M. The efficacy of various modalities of psychotherapy for personality disorders: a systematic review of the evidence and clinical recommendations. Int Rev Psychiatry. 2007;19(1):25-38. doi:10.1080/0954026060109539 (Pubitemid 46439707)
8. Bartak A, Spreeuwenberg MD, Andrea H, et al. Effectiveness of different modalities of psychotherapeutic treatment for patients with cluster C personality disorders: results of a large prospective multicentre study. Psychother Psychosom. 2010;79(1):20-30. doi:10.159/0254902
9. Briggs AH, Sculpher MJ, Claxton K. Decision Modelling for Health Economic Evaluation. New York, NY: Oxford University Press; 2006.
10. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59(1):12-19. doi:10.1037/02-06X.59.1.12
11. Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. New York, NY: Oxford University Press; 2005.
12. Glick HA, Doshi JA, Sonnad SS, et al. Economic Evaluation in Clinical Trials. New York, NY: Oxford University Press; 2007.
13. Health Care Insurance Board (CVZ). Dutch Guidelines for Pharmacoeconomic Research. 2006. http://www.ispor.org/PEguidelines/source/ HTAGuidelinesNLupdated2006.pdf.
14. De Jong CAJ, Derks FCH, Van Oel CJ, et al. Gestructureerd Interview voor de DSM-IV persoonlijkheidsstoornissen (SIDP-IV). Sint Oedenrode, The Netherlands: Stichting Verslavingszorg Oost-Brabant; 1996.
15. Pfohl B, Blum N, Zimmerman M. Structured Interview for DSM-IV Personality (SIDP-IV). Washington, DC: American Psychiatric Press; 1995.
16. Hakkaart-van Roijen L. Manual Trimbos/iMTA Questionnaire for Costs Associated With Psychiatric Illness [in Dutch]. Rotterdam, The Netherlands: Institute for Medical Technology Assessment; 2002.
17. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, et al. Manual for Cost Research: Methods and Unit-Prices for Economic Evaluations in Health Care [in Dutch], updated version. Amstelveen, The Netherlands: The Health Care Insurance Board (CVZ); 2004.
18. Health Care Insurance Board (CVZ). Pharmacotherapeutic Compass. 2005. http://www.fk.cvz.nl.
19. Consumer Price Index. Central Bureau for Statistics [in Dutch] Web site. http://statline.cbs.nl
20. van Roijen L, Essink-Bot ML, Koopmanschap MA, et al. Labor and health status in economic evaluation of health care: The Health and Labor Questionnaire. Int J Technol Assess Health Care. 1996;12(3):405-415. (Pubitemid 26295783)
21. Koopmanschap MA, Rutten FFH. A practical guide for calculating indirect costs of disease. Pharmacoeconomics. 1996;10(5):460-466. doi:10.2165/019053- 1961050-03 (Pubitemid 26359874)
22. Brooks R, Rabin R, de Charro F. The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective. London, England: Kluwer Academic Publishers; 2003.
23. Lamers LM, Stalmeier PFM, McDonnell J, et al. Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff [in Dutch]. Ned Tijdschr Geneeskd. 2005;149(28):1574-1578. (Pubitemid 40978328)
24. Life tables. Central Bureau for Statistics [in Dutch] Web site. http://statline.cbs.nl
25. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55. doi:10.1093/biomet/70.1.41
26. Bartak A, Spreeuwenberg MD, Andrea H, et al. The use of propensity score methods in psychotherapy research: a practical application. Psychother Psychosom. 2009;78(1):26-34. doi:10.159/016298
27. Fenwick E, Claxton K, Sculpher MJ. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 2001;10(8):779-787. doi:10.102/hec.635 (Pubitemid 34041389)
28. Barton GR, Briggs AH, Fenwick EAL. Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). Value Health. 2008;11(5):886-897. doi:10.1/j.1524-473.208.0358.x
29. Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions. Health Econ. 2004;13(5):405-415. doi:10.102/hec.903 (Pubitemid 38660390)
30. Council for Public Health and Health Care. Sensible and Sustainable Care [in Dutch]. The Hague, The Netherlands; 2006. www.rvz.net/data/download/Advies- DenZ-samenvatting-engels.doc
31. van Asselt ADI, Dirksen CD, Arntz A, et al. Out-patient psychotherapy for borderline personality disorder: cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy. Br J Psychiatry. 2008;192(6):450-457. doi:10.192/bjp.bp.106.03597 (Pubitemid 351809899)
32. Soeteman DI, Timman R, Trijsburg RW, et al. Assessment of the burden of disease among inpatients in specialized units that provide psychotherapy. Psychiatr Serv. 2005;56(9):1153-1155. doi:10.176/api.ps.56.9.153 (Pubitemid 41266849)
33. van Asselt ADI, Dirksen CD, Arntz A, et al. The EQ-5D: a useful quality of life measure in borderline personality disorder? Eur Psychiatry. 2009;24(2):79-85. doi:10.1016/j.eurpsy.208.1.01
34. Svartberg M, Stiles TC, Seltzer MH. Randomized, controlled trial of the effectiveness of short-term dynamic psychotherapy and cognitive therapy for cluster C personality disorders. Am J Psychiatry. 2004;161(5):810-817. doi:10.176/api.ajp.161.5.810 (Pubitemid 38625333)
35. Leichsenring F, Rabung S, Leibing E. The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis. Arch Gen Psychiatry. 2004;61(12):1208-1216. doi:10.101/archpsyc.61.12.1208 (Pubitemid 39602837)